Since 2015, Belgorod National Research University's forward-thinking open-access and peer-reviewed scholarly journal Research Result: Pharmacology and Clinical Pharmacology has been filling an essential gap as a scholarly venue for publications dealing with long-year research outcomes in pharmacology and clinical pharmacology.
Now, having moved to the high-tech journal publishing platform ARPHA (abbreviation standing for Authoring, Reviewing, Publishing, Hosting and Archiving), the rebranded Research Results in Pharmacology demonstrates its refreshed format in its first issue jointly published with open-access scholarly publisher and technology provider Pensoft via the journal's brand new website.
Continuing its tradition, the journal welcomes articles on various aspects within pharmacology, including papers devoted to molecular screening with the use of modern methods of proteomics, cellular technologies, results of experimental studies in modeling abnormalities in laboratory animals and clinical studies in the field of pharmacotherapy, pharmacokinetics, pharmacoepidemiology, personalised therapy, multicenter studies and evidence-based medicine. All articles are published in English, with versions in Russian published on Belgorod National Research University's official website.
Apart from the evolution in its look-and-feel, thanks to the partnership with ARPHA, Research Results in Pharmacology now provides a long list of services at the disposal of all users - editors, reviewers, authors and readers alike, in order to ensure that articles are submitted, reviewed, published and disseminated rapidly and conveniently. To do this, the whole publication process takes place within ARPHA's singular online environment.
Once published, each article is freely available in three formats (PDF, XML, HTML), enriched with a whole set of semantic enhancements, so that the articles, along with their data, are easy to discover, access and harvest by both humans and machines.
Amongst the high-tech perks greeting any online publication's visitor are the article-level metrics available thanks to the partnership between ARPHA and the revolutionary discovery and analytics tools Dimensions and Altmetric. By searching through millions of research articles, grant applications, clinical trials, as well as policy documents, news stories, blogs and social media posts, they allow for each article's references and citations in both the academic and the public sphere to be monitored in real time.
"I'm delighted to welcome this particular new member of the Pensoft's and ARPHA's family," says ARPHA's and Pensoft's founder and CEO Prof. Lyubomir Penev. "With our strong background in scholarly publishing, technology development and open science practices, I am certain that we are able to provide the right venue for a brilliant and enterprising journal such as Research Results in Pharmacology."
"I find our new partnership with ARPHA and Pensoft to be extremely advantageous for Research Results in Pharmacology, and this is already showing in our first issue since joining our efforts," says Prof. Mikhail Pokrovsky, Editor-in-Chief at Research Results in Pharmacology. "I would like to especially thank Lyubomir and his team for fully understanding and meeting our needs, resulting in a wonderful professional collaboration, as well as friendship."
Research Results in Pharmacology is the second Russian journal in ARPHA's and Pensoft's portfolios. Several new titles are expected to join them later this year.
ARPHA is the first end-to-end, narrative- and data-integrated publishing solution that supports the full life cycle of a manuscript, from authoring to reviewing, publishing and dissemination. ARPHA provides accomplished and streamlined production workflows that can be customized according to the journal's needs. The platform enables a variety of publishing models through a number of options for branding, production and revenue models to choose from.
Pensoft is an independent academic publishing company, well-known worldwide for its innovations in the field of semantic publishing, as well as for its cutting-edge publishing tools and workflows. In 2013, Pensoft launched the first ever end to end XML-based authoring, reviewing and publishing workflow, as demonstrated by the Pensoft Writing Tool (PWT) and the Biodiversity Data Journal (BDJ), now upgraded to the ARPHA Publishing Platform. Flagship titles include: Research Ideas and Outcomes (RIO), One Ecosystem, ZooKeys, Biodiversity Data Journal, PhytoKeys, MycoKeys, and more.
About Belgorod State National Research University:
Belgorod State National Research University is the leading University of Belgorod region targeted at solving research problems at international and national scale, as well as training highly qualified professionals capable of ensuring the competitiveness of the Russian Federation and Belgorod region on the global socioeconomic arena.
More than 23,000 students from all regions of Russia and 2,800 foreign students from 91 countries study there. BelSU is one of 29 national research universities of Russian Federation and a member of Association of Leading Russian Universities.
The University was also included in the list of the 19 higher education institutions and four scientific organizations, which are given the right to independently award candidate and doctor of science academic degrees, and create dissertation councils. BelSU is ranked 76-100 in the Global Ranking of Academic Subjects in Metallurgical Engineering (subject field "Engineering"). Since 2009 Belgorod State National Research University has been a head university of Shanghai Cooperation Organization (SCO) Network University in the priority area of Nanotechnology.
Prof. Lyubomir Penev, ARPHA and Pensoft
Prof. Mikhail Pokrovsky